Announcements Trials
Browse Landscape

Phase

Phase 2 54Phase 1 33Phase 1/2 26Phase 3 24Phase NA 4Phase 4 4Phase 2/3 3

Status

Completed 3Unknown 1

Sponsor Class

OTHER 11INDUSTRY 4OTHER_GOV 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Genitourinary 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 1Neoplasms 1Glioblastoma 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma 1Breast Neoplasms 1

Interventions

Zoledronic Acid 23Bevacizumab 13nilotinib 12Docetaxel 12Paclitaxel 11Everolimus 11Letrozole 10Imatinib Mesylate 10Capecitabine 10Erlotinib Hydrochloride 9Drug Therapy 9Carboplatin 9pegfilgrastim 8enzalutamide 8Trastuzumab 7Oxycodone 7Nivolumab 7Imiquimod 7Gemcitabine 7Epoetin Alfa 7icotinib 6Rituximab 6Prednisone 6Pemetrexed 6Oxaliplatin 6Leuprolide 6Fulvestrant 6Diclofenac 6Dexamethasone 6Cisplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × INDUSTRY × Radiotherapy × Clear all
NCT00686725 2017-06-14

Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)

Merck Sharp & Dohme LLC

Phase 4 Completed
99 enrolled 15 charts
CNS

Glioblastoma

NCT00742222 2016-05-17

EXIBT

Xoft, Inc.

Phase 4 Completed
63 enrolled
Breast

Breast Neoplasms, Carcinoma, Carcinoma, Intraductal, Noninfiltrating

NCT00894153 2012-04-09

p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage

Shenzhen SiBiono GeneTech Co.,Ltd

Phase 4 Unknown
1,200 enrolled
Tumor-Agnostic

Neoplasms

NCT00590213 2008-01-25

COMART

AstraZeneca

Phase 4 Completed
125 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡